市場調查報告書

肌肉骨骼軟組織置換、再生用整形外科產品的全球市場

Orthobiologics for Musculoskeletal Soft Tissue Replacement and Regeneration

出版商 Datamonitor Healthcare 商品編碼 914883
出版日期 內容資訊 英文 66 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
肌肉骨骼軟組織置換、再生用整形外科產品的全球市場 Orthobiologics for Musculoskeletal Soft Tissue Replacement and Regeneration
出版日期: 2019年10月11日內容資訊: 英文 66 Pages
簡介

本報告提供全球肌肉骨骼軟組織的置換、再生整形外科產品的技術、市場趨勢的分析,全球整體及各地區、主要國家 (美國、日本、歐洲主要5個國家 (EU5:法國、德國、義大利、西班牙、英國) 等) 為對象,相關傷害的發生數量和患者數,現有產品的組合,開發中的產品的概要,今後的市場趨勢預測,主要企業的簡介與市場佔有率等資訊彙整,為您概述為以下內容。

摘要整理

第1章 肌肉骨骼軟組織的置換、再生用的整形外科產品

  • 軟骨置換、再生
    • 異體移植片移植
    • 細胞再生
  • 半月軟骨的修復、置換、再生
    • 異體移植片的移植
    • 支架
  • 肌腱、韌帶的修復、置換、再生
    • 異體移植片移植
    • 自我細胞治療
    • 支架
  • 參考文獻

第2章 肌肉骨骼軟組織置換、再生用整形外科產品的市場

  • 整體市場規模的預測
    • 推動及阻礙市場要素
    • 市場預測:各地區
  • 市場分析:軟骨置換、再生市場
  • 市場分析:半月軟骨修復、置換、再生
  • 市場分析:韌帶、肌腱的修復、置換、再生
  • 企業分析
  • 參考文獻

附錄:企業一覽

目錄
Product Code: #MDT19017

Overview

This medical market and technology report provides a comprehensive discussion of the global market for orthobiologics for musculoskeletal soft tissue replacement and regeneration (including cell-based therapies and tissue scaffolds and grafts). Geographic markets covered by this analysis include the US, Japan, five major EU markets (France, Germany, Italy, Spain, and the UK), and the Rest of World (RoW), which includes all other countries.

This report provides the following useful information:

  • prevalence of sports injuries
  • prevalence of osteoarthritis
  • product portfolios offered by leading manufacturers
  • new technologies under development
  • global market forecasts, by region
  • analyses of the top competitors and their market shares.

TABLE OF CONTENTS

Executive Summary

  • i. Market analysis
  • ii. Competitive analysis
  • iii. Methodology
  • Exhibit ES-1: Orthobiologics for musculoskeletal soft tissue replacement and regeneration combined market forecast, by country/region ($m), 2018-23
  • Exhibit ES-2: Orthobiologics for musculoskeletal soft tissue replacement and regeneration, share by country/region, 2018
  • Exhibit ES-3: Orthobiologics for musculoskeletal soft tissue replacement and regeneration combined market forecast, by product segment ($m), 2018-23
  • Exhibit ES-4: Global market for orthobiologic products for musculoskeletal soft tissue replacement and regeneration, share by supplier, 2018

1. Orthobiologic Products for Musculoskeletal Soft Tissue Replacement and Regeneration

  • 1.1 Cartilage replacement and regeneration
    • 1.1.1 Allograft transplants
    • 1.1.2 Cellular regeneration
  • 1.2. Meniscus repair, replacement, and regeneration
    • 1.2.1 Allograft transplants
    • 1.2.2 Scaffolds
  • 1.3 Tendon and ligament repair, replacement, and regeneration
    • 1.3.1 Allograft transplants
    • 1.3.2 Autologous cell therapy
    • 1.3.3 Scaffolds
  • 1.4 Bibliography
  • Exhibit 1-1: Selected cartilage allograft products
  • Exhibit 1-2: Selected scaffold products for cartilage reconstruction
  • Exhibit 1-3: Selected emerging cartilage scaffold products
  • Exhibit 1-4: Selected meniscus allograft products
  • Exhibit 1-5: Selected meniscus scaffold products
  • Exhibit 1-6: Selected tendon allograft products
  • Exhibit 1-7: Selected scaffold products for tendon and ligament regeneration
  • Exhibit 1-8: Selected emerging scaffold products for tendon and ligament regeneration

2. Market for Orthobiologics for Musculoskeletal Soft Tissue Replacement and Regeneration

  • 2.1 Combined market forecast
    • 2.1.1 Market drivers and limiters
    • 2.1.2 Market forecast: by region
  • 2.2 Cartilage replacement and regeneration products, market analysis
  • 2.3 Meniscus replacement and regeneration products, market analysis
  • 2.4 Ligament and tendon regeneration and replacement products, market analysis
  • 2.5 Competitive analysis
  • 2.6 Bibliography
  • Exhibit 2-1: Orthobiologics for musculoskeletal soft tissue replacement and regeneration combined market forecast, by country/region ($m), 2018-23
  • Exhibit 2-2: Orthobiologics for musculoskeletal soft tissue replacement and regeneration combined market forecast, by product segment ($m), 2018-23
  • Exhibit 2-3: Reimbursement levels for orthobiologics for musculoskeletal soft tissue replacement and regeneration, US
  • Exhibit 2-4: Selected private insurance reimbursement coverage for cartilage and meniscus orthobiologics, US
  • Exhibit 2-5: Orthobiologics for musculoskeletal soft tissue replacement and regeneration, share by country/region, 2018
  • Exhibit 2-6: MACI's approved indications, US
  • Exhibit 2-7: MACI's potential annual US market
  • Exhibit 2-8: Cartilage replacement and regeneration products, market forecast ($m), by country/region, 2018-23
  • Exhibit 2-9: Meniscus replacement and regeneration products, market forecast ($m), by country/region, 2018-23
  • Exhibit 2-10: Ligament and tendon replacement and regeneration products, market forecast ($m), by country/region, 2018-23
  • Exhibit 2-11: Global market for orthobiologic products for musculoskeletal soft tissue replacement and regeneration, share by supplier, 2018

APPENDIX: COMPANY LISTING

Back to Top